Fig. 2From: Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careTrial flow chart — randomisation, treatment, and follow-up. For participants recruited following Protocol v5.0, follow-up concludes at 6 monthsBack to article page